{"schema_version":"secwatch.filing_event.v1","accession":"0001140859-23-000082","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.048903+00:00","generated_at":"2026-06-16T02:41:40.381703+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AmerisourceBergen Q2 revenue $63.5B (+9.9%), adj EPS $3.50 (+8.7%), raises FY guidance","bullets":["Revenue $63.5B, up 9.9% YoY; GAAP diluted EPS $2.13, adjusted $3.50 (up 8.7%).","Adjusted diluted EPS guidance raised to $11.70-$11.90 from $11.50-$11.75 for FY2023.","Announced agreement to invest in OneOncology; strategic capital deployment.","Operating income: GAAP $561M, adjusted $932M; gross profit $2.3B GAAP, $2.4B adjusted."],"urls":{"canonical":"https://secwatch.observer/filing/0001140859-23-000082","json":"https://secwatch.observer/filing/0001140859-23-000082.json","markdown":"https://secwatch.observer/filing/0001140859-23-000082.md","text":"https://secwatch.observer/filing/0001140859-23-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/0001140859-23-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/abc-20230502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T02:41:40.381703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab4f470ab15b22190ed1ac5ea8bd1becf4f653d2","claim":"Cencora, Inc. reported fiscal 2023 results: EPS 11.70 to 11.90. Guidance raised.","evidence_excerpt":"Adjusted diluted EPS guidance has been raised from the previous range of $11.50 to $11.75 to a range of $11.70 to $11.90.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/0001140859-23-000082-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2023"},{"label":"EPS","value":"11.70 to 11.90"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"b4a5daa18280ab7f3d5778b79229724996f17d46","claim":"Cencora, Inc. reported fiscal quarter ended March 31, 2023 results: revenue 63.5 billion, net income 435M, EPS 2.13.","evidence_excerpt":"--- EX-99.1 (EX-99.1) --- AmerisourceBergen Corporation 1 West First Avenue Conshohocken, PA 19428 AMERISOURCEBERGEN REPORTS FISCAL 2023 SECOND QUARTER RESULTS Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $2.13 and Adjusted Diluted EPS of $3.50 Adjusted Diluted EPS Guidance Range","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/0001140859-23-000082-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter ended March 31, 2023"},{"label":"Revenue","value":"63.5 billion"},{"label":"Net income","value":"435M"},{"label":"EPS","value":"2.13"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}